D. Velakoulis

721. The markers in neuropsychiatric disorders study (the MiND study): blood biomarkers to distinguish dementia from psychiatric disorders, and accessible technologies to enable global translation

Abstract Background Despite significant advances, delay to diagnosis of dementia and misdiagnosis is still common, which significant negative impacts for patients, their families, and healthcare systems and clinical trials. There remains a great need for simple and globally available via markers to improve timely and a...